Tyrosine hydroxylase antisense gene therapy causes hypotensive effects in the spontaneously hypertensive rats

Citation
T. Kumai et al., Tyrosine hydroxylase antisense gene therapy causes hypotensive effects in the spontaneously hypertensive rats, J HYPERTENS, 19(10), 2001, pp. 1769-1773
Citations number
17
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF HYPERTENSION
ISSN journal
02636352 → ACNP
Volume
19
Issue
10
Year of publication
2001
Pages
1769 - 1773
Database
ISI
SICI code
0263-6352(200110)19:10<1769:THAGTC>2.0.ZU;2-4
Abstract
We investigated the effect of antisense oligodeoxynucleotides (AS ODN) agai nst tyrosine hydroxylase (TH) on hypertension and sympathetic nervous syste m activity in spontaneously hypertensive rats (SHR). Systolic blood pressur e (SBP) in SHR treated with TH AS ODN (50,200 mug/rat, i.v.) was significan tly lower than that of control SHR. Epinephrine and norepinephrine levels, TH activity, and TH protein levels in the adrenal medulla of SHR were reduc ed concomitant with TH AS ODN treatment-induced changes in SBP. In contrast , TH AS ODN (200 mug/rat) had no effect on SBP in Wistar-Kyoto rats (WKY), despite significantly decreased catecholamine levels, TH activity, and TH p rotein levels. These findings suggest that peripheral systemic injection of TH AS ODN may be effective as hypotensive therapy in SHR. (C) 2001 Lippinc ott Williams & Wilkins.